Displaying 13 - 24 of 82
Immune-Mediated and Cholestatic Diseases

GSK: Providing Better Care in PBC: Innovative Solutions for Today’s Challenges (Complete Session)

Webcasts
View
Viral Hepatitis

AbbVie: Educate, Motivate, Prioritize, Adapt: Decentralizing Care to Eliminate HCV (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity
Introduction

Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity
Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients

Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients

Webcasts
View
Metabolism, Alcohol & Toxicity
Clinical cases presentation and discussion

Clinical cases presentation and discussion

Webcasts
View
Metabolism, Alcohol & Toxicity
FAST score for identification of active fibrotic NASH

FAST score for identification of active fibrotic NASH

Webcasts
View
Metabolism, Alcohol & Toxicity
Q&A

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity
Wrap-up

Wrap-up

Webcasts
View
Metabolism, Alcohol & Toxicity
Treatment strategies for improvement of NAFLD/NASH

Treatment strategies for improvement of NAFLD/NASH

Webcasts
View
Metabolism, Alcohol & Toxicity
Obesity: what do we need to know and why?

Obesity: what do we need to know and why?

Webcasts
View
Metabolism, Alcohol & Toxicity
Introduction

Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity
Targeting obesity as a metabolic treatment approach in NAFLD/NASH

Targeting obesity as a metabolic treatment approach in NAFLD/NASH

Webcasts
View
Displaying 13 - 24 of 82